Search for: "Bayer AG"
Results 421 - 440
of 641
Sort by Relevance
|
Sort by Date
19 Jan 2011, 8:06 am
Many states have already (x) increased the retirement age and required years of service for new hires, (y) bumped up the amount new workers pay toward their benefits, and (z) reduced annual cost-of-living increases. [read post]
18 Jan 2011, 3:10 am
., 482 F.3d at 1319; see also Bayer AG, 298 F.3d at 1381. [read post]
13 Jan 2011, 10:10 am
Bayer AG , which relates to CIPRO, had been heard in the Second Circuit Court of Appeals. [read post]
11 Jan 2011, 11:07 pm
General Steve Burrill makes predictions for the biotech industry in 25th annual report (Patent Docs) Australia: ‘Innovation’ patents in Australia – AMI innovation patent and US investment (IPBiz) Australia: Extension of patent term for pharmaceuticals in Australia: AAT decision in LTS Lohmann Therapie Systeme AG and Schwarz Pharma Ltd and Commissioner of Patents (Patent Baristas) US: CAFC : Single embodiment commercial success: In re Glatt Air Techniques (Patently-O)… [read post]
11 Jan 2011, 1:51 pm
Bayer AG, Dkt. 10-762. [read post]
10 Jan 2011, 11:49 am
Bayer AG (On Petition for a Writ of Certiorari 2011) Ordinarily, a patent is valuable when it offers some degree of market exclusivity. [read post]
10 Jan 2011, 5:54 am
Bayer AG, et al. [read post]
8 Jan 2011, 2:18 pm
IN/PCT/2002/410/CHE filed by Bayer Schering Pharma, AG claiming contraceptive formulation of drospirenone and ethinylestradiol (EE) marketed as Yasmin and Yaz/Yasminelle in Europe and the US. [read post]
8 Jan 2011, 2:18 pm
IN/PCT/2002/410/CHE filed by Bayer Schering Pharma, AG claiming contraceptive formulation of drospirenone and ethinylestradiol (EE) marketed as Yasmin and Yaz/Yasminelle in Europe and the US. [read post]
22 Dec 2010, 3:01 am
(Patent Docs) Yaz (Drospirenone, Ethinyl estradiol) – Bayer settles with Teva in multiple Yaz patent disputes: Bayer v Teva (Patent Docs) [read post]
13 Dec 2010, 9:55 pm
Bayer CropScience AG v. [read post]
10 Dec 2010, 7:02 am
Holly Hayes is a mediator at Karl Bayer, Dispute Resolution Expert where she focuses on mediation of health care disputes. [read post]
17 Nov 2010, 1:48 am
(Patent Baristas) A round up of international events – Access and Benefit Sharing Protocol; review of Para 6 system; concerns with ACTA’s compatibility with TRIPS(Spicy IP) Compromise UN protocol treaty against biopiracy adopted in Japan (IP Watch) (Innovation Law Blog) TRIPS Council discusses efficacy of ACTA, public health amendment (IP Watch) Altering genes in crops (IP Osgoode) Asia Pacific Pharmas moving away from generics (GenericsWeb) Belgium Commercial Court: No faultless… [read post]
10 Nov 2010, 3:33 am
Department of Defense - http://tinyurl.com/37dul83 Frayman Group and NetDocuments Join Forces to Provide Seamless Experience for Joint Law Firm Customers - http://litn.eu/tfg05 FTI Consulting Misses Estimate - http://tinyurl.com/22spur3 GGO and ABC Digital Solutions Announce Electronic Discovery Services - http://tinyurl.com/28xwukp Guidance Software Reduces Q3 Net Loss to USD763,000 - http://tinyurl.com/2cbdena Huron Consulting Group Announces the Acquisition of TRILANTIC -… [read post]
2 Nov 2010, 4:46 am
Bayer Corp., 2010 WL 3834327 (N.D. [read post]
27 Oct 2010, 8:30 am
In Bayer AG v. [read post]
24 Oct 2010, 7:34 am
Specifically, the agents mentioned by the FDA as possibly being more likely to result in the skin condition are GE Healthcare's Omniscan, Bayer AG's Magnevist and Covidien's Optimark. [read post]
18 Oct 2010, 6:36 am
Of respondents age 55 and older, 60.5% said they’ve been sued once and 39.2% had been sued at least twice. [read post]
18 Oct 2010, 1:47 am
An estimated 95% of cases occur in Asia and Africa and up to 60% of cases are in children under 15 years of age. [read post]
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated protein from B… [read post]
